EUVIMEDEUVIMED entdecken
Crossref

Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling

Nayan Rishi, Harsh Kumar Mathur, Jitendra Arya, Sagar Rana

Journal of Advances in Microbiology Research · 01.06.2026 · 7 (6) · 21-30

DOI: 10.22271/micro.2026.v7.i6a.369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advances in Microbiology Research, online erschienen am 01.06.2026. Verfasst von Nayan Rishi und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rishi, N., Mathur, H. K., Arya, J., & Rana, S. (2026). Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling. Journal of Advances in Microbiology Research, 7(6), 21-30. https://doi.org/10.22271/micro.2026.v7.i6a.369

Vancouver

Rishi N, Mathur HK, Arya J, Rana S. Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling. Journal of Advances in Microbiology Research. 2026;7(6):21-30. doi:10.22271/micro.2026.v7.i6a.369

BibTeX
@article{Rishi2026,
  author = {Rishi, Nayan and Mathur, Harsh Kumar and Arya, Jitendra and Rana, Sagar},
  title = {Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling},
  journal = {Journal of Advances in Microbiology Research},
  year = {2026},
  volume = {7},
  number = {6},
  pages = {21--30},
  doi = {10.22271/micro.2026.v7.i6a.369}
}
Kostenlos starten →